Landscapes / Companies

Bukwang Pharmaceutical not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved in other
Next date
Lurasidone, Phase 3 trial completes
Drugs
1
in active trials · 5 in all
Trials
1 active
7 since 2021

Drugs1

DrugHow it worksPartnerStageNext dateDetails
Atypical antipsychotic
Approved in other Oct 2027Phase 3 trial completes

About

No active trial
Apatinib mesylate, Clevudine, JM-010, SOL-804-F
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Bukwang Pharmaceutical

Following is part of Solo: you see every change to Bukwang Pharmaceutical the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in